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In this Issue of Schizophrenia Research, the paper “Risk and resilience brain networks in 
treatment-resistant schizophrenia” by Ganella and colleagues (2017) has refreshingly focused 
not only on investigating which brain networks may confer risk to schizophrenia, but also which 
ones may confer resilience to the illness in individuals who have a genetic vulnerability but 
remain well. 
 
The paper presents data from a cross-sectional neuroimaging study conducted on individuals 
with treatment resistant schizophrenia, unaffected first-degree family relatives of patients with 
this diagnosis, and healthy controls. In this sample, the authors used functional Magnetic 
Resonance Imaging (fMRI) to evaluate whether resting-state functional brain connectivity (rs-
FC) could represent a risk or resilience endophenotype for schizophrenia. Indeed, resting 
state is an approach that can be useful to evaluate the brain’s functional organization and its 
alterations across diseases. The Authors’ choice was dictated by accumulating evidence that 
in individuals with schizophrenia there is often a decrease in resting state signal or functional 
connectivity, particularly in medial, dorsolateral and ventrolateral prefrontal cortex, and 
temporal lobe, as highlighted in a recent review published in this Journal (Mwansisya et al., 
2017). However, in individuals at illness onset and in those “at risk” of the disease, for example 
because of a genetic vulnerability conferred by having an affected first degree relative, the 
evidence from resting state studies has been less consistent, with some studies reporting 
decreased, and others increased, connectivity of the same brain areas often reported as 
decreased in individuals with established schizophrenia.  
 
Elegantly, this paper sought to identify not only brain networks indicative of risk for 
schizophrenia, but also any unique brain network indicative of resilience in the unaffected 
relatives of patients with a particularly severe form of the disease, treatment resistant 
schizophrenia. They additionally evaluated the efficiency of such networks, with measures that 
quantify the network ability to exchange information, either at neighbour or whole network 
level.  
 The findings of the paper are interesting in that both patients and unaffected relatives were 
found to share several reductions in resting state connectivity, particularly in temporal and 
occipital lobes, which were operationalised as schizophrenia risk markers. In contrast, 
alterations unique to the unaffected relatives were much rarer. These were mostly 
circumscribed to temporal and subcortical areas, particularly middle temporal pole and 
posterior cingulum. The authors also found that in both patients and unaffected relatives, 
compared to controls global efficiency of the network was reduced. Interestingly, this is a 
finding that is consistent with our recent structural imaging reports of reduced structural global 
efficiency and less integrated networks in patients with a first episode of schizophrenia and 
other psychoses who do not respond to treatment in the first 12 weeks after illness onset 
(Crossley et al., 2017, Palaniyappan et al., 2016).  
 
The Authors attempt to evaluate networks that may underlie resilience is particularly valuable, 
as it tries to fill a critical gap in the literature. We have seen, over and over again, that risk for 
schizophrenia is associated with almost every risk factor associated with psychiatric diseases. 
We have seen these varying from genetic vulnerability, to childhood trauma and life events, 
to obstetric complications, immunological activation, social deprivation, urbanicity, illicit 
substances and so on. For example, we have recently shown that early and life trauma, and 
immune activation are associated with psychosis, and furthermore, that immune activation 
and an altered biological response to stress particularly characterise those individuals who do 
not respond to treatment evident in patients (Mondelli et al., 2011, Mondelli et al., 2015). We 
have however been unable to establish, or even to start establishing, why so many individuals 
exposed to these risk factors do not develop the disorder. While measures of increased risk, 
like odds ratios and relative risk, may be informative, they tell us very little as to what protects 
exposed individuals from becoming unwell.  
 
In mental health, resilience is a term often used in the context of the long- and short-term 
consequences of severe adversity and extreme trauma. Still, while we have excellent 
operational definitions and measures of adversity, we lack a common and reliable definition 
of resilience. When thinking of resilience in the context of neurobiological systems, the 
definition provided by Ann Masten, internationally known for her work on competence, risk 
and resilience, and child development seems most appropriate. She refers to resilience as 
“the capacity of a dynamic system to adapt successfully to disturbances that threaten the 
viability, the function, or the development of that system” (Masten, 2014). In this framework, 
the neurobiological basis of resilience could represent the crucial system linking vulnerability 
and experience on one side, and the emergence of the illness and its adverse outcomes on 
the other side. Interestingly, 75 percent of cases of adult mental illnesses, such as 
schizophrenia, depression and bipolar disorder, emerge before the age of 18 years, with 50% 
evident before age 15 (Kim-Cohen et al., 2003). This points to late childhood and adolescence 
as times when risk and resilience factors may impact most on brain developmental 
trajectories, to eventually give rise to mental disorders. Studying brain maturation, with a 
longitudinal approach, could truly advance our understanding of how a dynamic and evolving 
system like the brain may be shaped differently to give origin or offer resilience to the onset of 
mental health problems. In this sense, resilience could be considered as a process, resulting 
from the engagement of the individual with its environment (Southwick et al., 2014). In this 
framework, the presence of a genetic vulnerability and a history of early adversity could push 
neurobiological systems -including the brain- to develop differently than in those individuals 
with the same vulnerability, but with the buffer effect of growing up in a warm and safe 
environment.  
 
Studies like the one published in this issue of the journal can move us closer to understanding 
the mechanisms of resilience. Still, to better understand what protects vulnerable individuals 
from developing the disorder, or to recover from it, we need to establish how experience, 
environment, and biological systems interact at ages that are crucial for neurodevelopment. 
These times represent pluripotent risk phases, when a number of subsequent 
psychopathological outcomes are possible. Investigating the brain determinants of poor and 
good mental health in these periods could help identify the specific trajectories that confer risk 
and require interventions (psychological or pharmacological), and distinguish them from those 
that safeguard against adverse mental health outcomes. 
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